PT Siloam International Hospitals Tbk (IDX:SILO)
Indonesia · Delayed Price · Currency is IDR 2,730.00
-10.00 (-0.36%)
Apr 9, 2026, 4:02 PM WIB
IDX:SILO Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 12,847,434 | 12,207,563 | 11,190,511 | 9,518,012 | 9,381,891 | |
Revenue Growth (YoY) | 5.24% | 9.09% | 17.57% | 1.45% | 31.95% |
Cost of Revenue | 7,900,640 | 7,559,090 | 6,942,765 | 6,175,478 | 5,965,221 |
Gross Profit | 4,946,794 | 4,648,473 | 4,247,746 | 3,342,534 | 3,416,670 |
Selling, General & Admin | 3,022,140 | 2,692,387 | 2,369,046 | 2,154,189 | 2,218,108 |
Other Operating Expenses | 245,231 | 330,527 | 116,368 | 149,336 | 103,091 |
Operating Expenses | 3,267,371 | 3,022,914 | 2,485,414 | 2,303,525 | 2,321,199 |
Operating Income | 1,679,423 | 1,625,559 | 1,762,332 | 1,039,009 | 1,095,471 |
Interest Expense | -155,920 | -57,477 | -51,860 | -38,332 | -37,916 |
Interest & Investment Income | 21,544 | 29,775 | 21,975 | 29,917 | 19,147 |
Earnings From Equity Investments | - | - | -91 | -78 | - |
Currency Exchange Gain (Loss) | - | -27,359 | -27,147 | -16,677 | -20,968 |
Other Non Operating Income (Expenses) | - | -38,579 | -31,900 | -29,532 | -27,069 |
EBT Excluding Unusual Items | 1,545,047 | 1,531,919 | 1,673,309 | 984,307 | 1,028,665 |
Gain (Loss) on Sale of Investments | - | -11,131 | - | - | - |
Asset Writedown | - | -160,426 | -6,900 | - | -55,800 |
Pretax Income | 1,545,047 | 1,360,362 | 1,666,409 | 984,307 | 972,865 |
Income Tax Expense | 380,870 | 410,248 | 419,365 | 273,926 | 272,681 |
Earnings From Continuing Operations | 1,164,177 | 950,114 | 1,247,044 | 710,381 | 700,184 |
Minority Interest in Earnings | -51,514 | -47,962 | -35,761 | -13,886 | -26,067 |
Net Income | 1,112,663 | 902,152 | 1,211,283 | 696,495 | 674,117 |
Net Income to Common | 1,112,663 | 902,152 | 1,211,283 | 696,495 | 674,117 |
Net Income Growth | 23.33% | -25.52% | 73.91% | 3.32% | 480.32% |
Shares Outstanding (Basic) | 12,986 | 12,982 | 12,987 | 9,846 | 12,934 |
Shares Outstanding (Diluted) | 12,988 | 13,039 | 13,035 | 9,867 | 12,937 |
Shares Change (YoY) | -0.39% | 0.03% | 32.11% | -23.73% | -0.43% |
EPS (Basic) | 85.68 | 69.49 | 93.27 | 70.74 | 52.12 |
EPS (Diluted) | 85.67 | 69.19 | 92.92 | 70.59 | 52.11 |
EPS Growth | 23.82% | -25.54% | 31.63% | 35.46% | 482.88% |
Free Cash Flow | 669,144 | 692,816 | 670,608 | 505,036 | 1,408,498 |
Free Cash Flow Per Share | 51.52 | 53.13 | 51.45 | 51.18 | 108.87 |
Dividend Per Share | - | - | 20.000 | 19.670 | - |
Dividend Growth | - | - | 1.68% | - | - |
Gross Margin | 38.50% | 38.08% | 37.96% | 35.12% | 36.42% |
Operating Margin | 13.07% | 13.32% | 15.75% | 10.92% | 11.68% |
Profit Margin | 8.66% | 7.39% | 10.82% | 7.32% | 7.18% |
Free Cash Flow Margin | 5.21% | 5.67% | 5.99% | 5.31% | 15.01% |
EBITDA | 2,168,506 | 2,081,545 | 2,239,849 | 1,545,181 | 1,602,513 |
EBITDA Margin | 16.88% | 17.05% | 20.02% | 16.23% | 17.08% |
D&A For EBITDA | 489,083 | 455,986 | 477,517 | 506,172 | 507,042 |
EBIT | 1,679,423 | 1,625,559 | 1,762,332 | 1,039,009 | 1,095,471 |
EBIT Margin | 13.07% | 13.32% | 15.75% | 10.92% | 11.68% |
Effective Tax Rate | 24.65% | 30.16% | 25.17% | 27.83% | 28.03% |
Revenue as Reported | 12,847,434 | 12,207,563 | 11,190,511 | 9,518,012 | 9,381,891 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.